Seres Therapeutics, Inc.
USD5.33
+0.15 (+2.90%)
CEO
Richard N. Kender
IPO Date
2015-06-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.30
Prev. Close
$5.18
Day Low
$5.13
Day High
$5.69
52W Low
$5.04
52W High
$29.98
Market Cap
$0.05B
Volume
0.06M
| 50,000 |
| $9.13 |
| 10 Jul 2026 | Henn Matthew R | See Remarks | A-Award | Acquired | 25,000 | $9.13 |
| 10 Jul 2026 | Thorell Marella | See Remarks | A-Award | Acquired | 7,500 | $9.13 |
| 10 Jul 2026 | Fraser Claire | director | A-Award | Acquired | 6,500 | $7.14 |
| 10 Jul 2026 | Dere Willard H | director | A-Award | Acquired | 6,500 | $7.14 |
| 10 Jul 2026 | Ausiello Dennis A | director | A-Award | Acquired | 6,500 | $7.14 |
| 10 Jul 2026 | Shaff Eric D. | director | A-Award | Acquired | 6,500 | $7.14 |
| 10 Jul 2026 | Rosiello Robert L. | director | A-Award | Acquired | 6,500 | $7.14 |
| 10 Jul 2026 | Berenson Stephen | director | A-Award | Acquired | 6,500 | $7.14 |